- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 29.08. | Bullion Gold Resources Corp (2): Bullion Gold samples up to 15.5% Cu, 137 g/t Ag at Bodo | 1 | Stockwatch | ||
| 28.08. | Bullion Gold Resources Corporation: Bullion Samples Up to 15.5% Cu, 137 G/t Ag and 6.85 G/t Au at the Bodo Project and Identifies a New Gold Target at Holton Creek | 319 | Newsfile | Montreal, Quebec--(Newsfile Corp. - August 28, 2025) - Bullion Gold Resource Corp. (TSXV: BGD) ("Bullion Gold" or the "Company") is pleased to announce the first assay results from surface sampling... ► Artikel lesen | |
| 27.08. | Bullion Gold Resources Corp (2): Bullion, Olympio drill 14.5m of 1.96 g/t Au at Bousquet | 1 | Stockwatch | ||
| 26.08. | Bullion Gold Resources Corporation: Continued Success of Bousquet Gold Drilling with First Holes at Decoeur Prospect | 337 | Newsfile | Montreal, Quebec--(Newsfile Corp. - August 26, 2025) - Bullion Gold Resources (TSXV: BGD) ("Bullion Gold" or "The Company") and its partner Olympio Metals Limited ("Olympio") are pleased to announce... ► Artikel lesen | |
| 18.08. | ABC Bullion: Gold falls, silver 'muted' as Bitcoin rallies: Gold prices fell marginally week-on-week, easing ... | 4 | Mining.com.au | ||
| 14.08. | Bullion Gold Resources Corp (2): Bullion Gold completes field prospecting at Bodo | 2 | Stockwatch | ||
| BULLION GOLD RESOURCES Aktie jetzt für 0€ handeln | |||||
| 14.08. | Bullion Gold Resources Corporation: Bullion Gold Expands the Lac Rivon West Copper System, Tichegami - Eeyou Istchee Baie-James | 396 | Newsfile | Montreal, Quebec--(Newsfile Corp. - August 14, 2025) - Bullion Gold Resources (TSXV: BGD) ("Bullion Gold" or the "Company") announces the completion of a field prospecting program on its wholly owned... ► Artikel lesen | |
| 13.08. | Bullion Gold Resources Corp (2): Bullion drilling shows shallow gold over 200 m strike | 1 | Stockwatch | ||
| 13.08. | Bullion Gold Resources Corporation: Drilling at Amadee Prospect Confirms Shallow Gold Mineralisation | 458 | Newsfile | Montreal, Quebec--(Newsfile Corp. - August 12, 2025) - Bullion Gold Resources (TSXV: BGD) ("Bullion Gold" or the "Company") and its partner Olympio Metals Limited are pleased to announce that results... ► Artikel lesen | |
| 05.08. | Bullion Gold Resources Corporation: Further High-Grade Gold Intersections at Bousquet | 387 | Newsfile | Montreal, Quebec--(Newsfile Corp. - August 5, 2025) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or the "Company") and its partner Olympio Metals Limited are pleased to announce that... ► Artikel lesen | |
| 29.07. | Bullion Gold Resources Corp (2): Bullion partner drills 7.9 m of 6.2 g/t Au at Bousquet | 2 | Stockwatch | ||
| 28.07. | Bullion Gold Resources Corporation: High-Grade Gold up to 42.3 g/t Confirmed in First Two Drillholes at Bousquet | 321 | Newsfile | Montreal, Quebec--(Newsfile Corp. - July 28, 2025) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or the "Company") announces that its Australian partner Olympio Metals has successfully... ► Artikel lesen | |
| 10.07. | Bullion Gold Resources Corp (2): Bullion Gold private placement | 1 | Stockwatch | ||
| 10.07. | Bullion Gold Resources Corp (2): Bullion's Bousquet optionee Olympio continues drilling | 1 | Stockwatch | ||
| 09.07. | Bullion Gold Resources Corporation: Bullion Gold Reports Olympio Metals Continues Drilling Program on Bousquet Beyond the Initial Planned Program | 317 | Newsfile | Montreal, Quebec--(Newsfile Corp. - July 9, 2025) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or the "Company") announces that its Australian partner Olympio Metals is continuing its... ► Artikel lesen | |
| 04.07. | Bullion Gold Resources Corp (2): Bullion Gold shareholders OK all resolutions at AGM | 4 | Stockwatch | ||
| 04.07. | Bullion Gold Resources Corporation: Bullion Gold Announces Results of Annual General Meeting | 606 | Newsfile | Montreal, Quebec--(Newsfile Corp. - July 3, 2025) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or "the Company") is pleased to announce that shareholders have approved of all resolutions... ► Artikel lesen | |
| 03.07. | Bullion Gold Resources Corp (2): Bullion Gold's Bousquet intersects visible gold | 1 | Stockwatch | ||
| 02.07. | Bullion Gold Resources Corporation: Exploration Work Advances on Bousquet, Bodo, and Langlade Projects | 465 | Newsfile | Montreal, Quebec--(Newsfile Corp. - July 2, 2025) - Bullion Gold Resources (TSXV: BGD) ("Bullion Gold" or "The Company") is pleased to provide an update to its shareholders and the public regarding... ► Artikel lesen | |
| 21.06. | Bullion Gold Resources Corp (2): Bullion Gold acquisition of Cadillac extension project | 2 | Stockwatch |
1 2 Weiter >>
37 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BIONTECH | 96,05 | +0,05 % | BioNTech: Chancen in Onkologie, Sorgen im Kurs | Die Aktie von BioNTech SE notiert aktuell bei 94,73 EUR. Nach dem beispiellosen Erfolg mit dem COVID-19-Impfstoff steht das Mainzer Biotech-Unternehmen vor der Herausforderung, seine Pipeline in Onkologie... ► Artikel lesen | |
| QIAGEN | 40,390 | +0,44 % | JEFFERIES stuft QIAGEN NV auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Qiagen mit einem Kursziel von 57 US-Dollar auf "Buy" belassen. Dies schrieb Analyst Tycho Peterson in seinem am Freitag... ► Artikel lesen | |
| NUVALENT | 80,89 | +1,53 % | Nuvalent, Inc.: Nuvalent Highlights Pipeline and Business Achievements, Reiterates Key Anticipated Milestones, and Reports Second Quarter 2025 Financial Results | Initiated rolling NDA submission for zidesamtinib for TKI pre-treated patients with advanced ROS1-positive NSCLC, with target completion in the third quarter of... ► Artikel lesen | |
| DYNE THERAPEUTICS | 14,220 | +7,40 % | Dyne Therapeutics, Inc.: Dyne Therapeutics Announces FDA Breakthrough Therapy Designation for DYNE-251 in Duchenne Muscular Dystrophy (DMD) | - Data from the DELIVER registrational expansion cohort is expected in late 2025, with a potential BLA submission for U.S. accelerated approval anticipated in early 2026 - WALTHAM, Mass., Aug.... ► Artikel lesen | |
| EVOTEC | 5,856 | +2,70 % | Evotec-Aktie: Ist das ein wichtiges Signal? | Die Evotec-Aktie bewegt sich weiterhin auf einem sehr niedrigen Niveau; am Montag verbessert sie sich aktuell um +1,5% und steht bei rund 6,10 €. Was bei dem deutschen Biotech-Unternehmen fehlt, sind... ► Artikel lesen | |
| RECURSION PHARMACEUTICALS | 4,610 | +1,99 % | Recursion Pharmaceuticals: Recursion Reports Second Quarter 2025 Financial Results and Provides Business Update | SALT LAKE CITY, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX) a leading clinical stage TechBio company decoding biology to radically improve lives, today reported business updates and... ► Artikel lesen | |
| AVIDITY BIOSCIENCES | 50,38 | +3,81 % | Avidity Biosciences, Inc.: Avidity Biosciences Reports Second Quarter 2025 Financial Results and Recent Highlights | Aligned with FDA on del-brax accelerated and full approval pathways for FSHD, reported positive topline data from Phase 1/2 FORTITUDE trial, and initiated global... ► Artikel lesen | |
| BEAM THERAPEUTICS | 20,890 | +12,68 % | Beam Therapeutics Announces U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to BEAM-101 for the Treatment of Sickle Cell Disease | CAMBRIDGE, Mass., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that... ► Artikel lesen | |
| SUMMIT THERAPEUTICS | 25,980 | +9,16 % | Summit Therapeutics stock maintains Buy rating at H.C. Wainwright on ivonescimab progress | ||
| MINERALYS THERAPEUTICS | 34,750 | +4,92 % | Mineralys reports positive subgroup data for hypertension drug | ||
| VERA THERAPEUTICS | 24,220 | +10,59 % | Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | BRISBANE, Calif., Sept. 05, 2025 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that, on September 4, 2025, the Compensation Committee of Vera's Board of Directors granted... ► Artikel lesen | |
| CG ONCOLOGY | 33,105 | +7,00 % | CG Oncology Inc.: CG Oncology Completes Enrollment in PIVOT-006 | - Rapid enrollment underscores high unmet need in intermediate-risk non-muscle invasive bladder cancer (NMIBC) -- One of the largest randomized phase 3 studies in this patient population will encompass... ► Artikel lesen | |
| MOONLAKE IMMUNOTHERAPEUTICS | 59,42 | -0,50 % | MoonLake Immunotherapeutics AG: MoonLake Immunotherapeutics Reports Second Quarter 2025 Financial Results and Provides a Business Update | Phase 3 VELA program in hidradenitis suppurativa (HS) on track for an expected primary endpoint readout around September 2025 and an expected submission of a Biologic License Application (BLA) in the... ► Artikel lesen | |
| ARS PHARMACEUTICALS | 10,090 | -5,61 % | Roth/MKM initiates ARS Pharmaceuticals stock with Buy rating on neffy potential | ||
| ARCUTIS BIOTHERAPEUTICS | 17,200 | +6,11 % | Arcutis Biotherapeutics, Inc.: Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | WESTLAKE VILLAGE, Calif., Sept. 05, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations... ► Artikel lesen |
BULLION GOLD RESOURCES CORPORATION gehört der Branche Biotechnologie an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BULLION GOLD RESOURCES CORPORATION finden Sie auf Wallstreet Online.